Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study

NCT03315832 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT03315832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03315832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
Lead sponsor
University Hospital, Limoges
Phase
Phase 2/3
Overall status
Withdrawn
Start date
January 2, 2023
Completion date
July 2, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiotensin receptor antagonists, aortic valve stenosis, heart valve prosthesis implantation, hypertrophy, left ventricular, transcatheter aortic valve replacement, valsartan